Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeo, Seung-Gu | - |
dc.date.accessioned | 2021-08-11T16:24:26Z | - |
dc.date.available | 2021-08-11T16:24:26Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1178-6930 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8432 | - |
dc.description.abstract | Prophylactic cranial irradiation (PCI) lowers the risk of brain metastasis (BM) and increases survival in small cell lung cancer (SCLC) patients, but it also entails a risk of neurocognitive dysfunction (NCD). One strategy to mitigate this neurotoxicity is hippocampus-avoiding (HA) whole-brain radiation therapy, as the hippocampus is mainly responsible for radiation-related NCD and hippocampal or perihippocampal metastases are rare. A few prospective clinical trials have demonstrated a reduction in NCD following HA whole-brain radiation therapy. The 59-year-old male patient described in this report had limited-stage SCLC and a complete response to thoracic chemoradiotherapy. Seven months after receiving HA-PCI of 25 Gy in 10 fractions using intensity-modulated radiation therapy, a 36 mm solitary metastasis was detected in the right perihippocampal region. The mass was surgically removed but the patient died 2 months later. The development of a solitary HA region metastasis is uncommon, considering that metastasis in this area usually occurs in patients with high numbers of BMs. Our case demonstrates the need for further validation of HA-PCI for SCLC patients in terms of both neurocognitive protection and the absence of compromise in terms of BM prevention. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Dove Medical Press Ltd | - |
dc.title | Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report | - |
dc.type | Article | - |
dc.publisher.location | 뉴질랜드 | - |
dc.identifier.doi | 10.2147/OTT.S143719 | - |
dc.identifier.scopusid | 2-s2.0-85027566527 | - |
dc.identifier.wosid | 000407577500002 | - |
dc.identifier.bibliographicCitation | OncoTargets and Therapy, v.10, pp 4017 - 4021 | - |
dc.citation.title | OncoTargets and Therapy | - |
dc.citation.volume | 10 | - |
dc.citation.startPage | 4017 | - |
dc.citation.endPage | 4021 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | WHOLE-BRAIN RADIOTHERAPY | - |
dc.subject.keywordPlus | RADIATION-THERAPY | - |
dc.subject.keywordPlus | PHASE-II | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | PRESERVATION | - |
dc.subject.keywordAuthor | hippocampus-sparing | - |
dc.subject.keywordAuthor | lung cancer | - |
dc.subject.keywordAuthor | neurotoxicity | - |
dc.subject.keywordAuthor | cognition | - |
dc.subject.keywordAuthor | brain metastasis | - |
dc.subject.keywordAuthor | whole brain radiation therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.